[Heart transplantation]

Norihide Fukushima1, Hikaru Matsuda

  • 1Department of Surgery, Osaka University Graduate School of Medicine, Suita, Japan.

Nihon Geka Gakkai Zasshi
|October 22, 2002
PubMed

Insights

Organ transplantation in Japan has advanced since 1999, with 77 patients receiving organs. Heart transplant (HTx) recipients, often supported by left ventricular assist devices (LVAS), showed promising survival rates.

Area of Science:

  • Medical Sciences
  • Surgical Innovation
  • Transplant Immunology

Context:

  • Organ transplantation from brain-dead donors commenced in Japan in February 1999.
  • The study covers the period from February 1999 to April 2002, encompassing over three years of transplant activity.
  • The Japan Organ Transplant Network (JOTN) manages organ transplant candidate registrations and allocations.

Purpose:

  • To report the initial outcomes and challenges of organ transplantation in Japan since its inception.
  • To evaluate the early results of heart transplantation (HTx), including the use of left ventricular assist devices (LVAS).
  • To document patient survival, complications, and recovery post-transplant.

Summary:

  • A total of 77 organ transplantations were performed from 19 donors, including heart, lung, liver, pancreas-kidney, pancreas alone, small intestine, and kidney.
  • For heart transplantation (HTx), 116 patients were registered as candidates. 13 underwent HTx in Japan and 8 abroad. 32 died while awaiting transplant.
  • Ten of 13 HTx recipients utilized a left ventricular assist device (LVAS). All 13 HTx recipients were alive at the time of reporting, with manageable rejection and infection episodes. Most recipients were discharged and returned to work.

Impact:

  • Demonstrates the feasibility and initial success of establishing a national organ donation and transplantation program in Japan.
  • Highlights the critical role of left ventricular assist devices (LVAS) in managing heart transplant candidates and improving outcomes.
  • Provides valuable data on patient survival, complication rates, and rehabilitation post-organ transplantation, informing future clinical practice and policy.

Related Concept Videos

Tissue Transplantation01:24

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...